Exact Mass: 527.3375570000001
Exact Mass Matches: 527.3375570000001
Found 257 metabolites which its exact mass value is equals to given mass value 527.3375570000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Daphniphylline
Daphniphylline is found in herbs and spices. Daphniphylline is isolated from the bract of Hibiscus sabdariffa (roselle Isolated from the bract of Hibiscus sabdariffa (roselle) [DFC]
LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z))
LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(0:0/22:5(7Z,10Z,13Z,16Z,19Z))
LysoPE(0:0/22:5(7Z,10Z,13Z,16Z,19Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/22:5(7Z,10Z,13Z,16Z,19Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
LysoPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Doramapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2].
12,13-epoxy-11-deoxo-6-oxo-5alpha,6-dihydrojervine N,O-diacetate
Doramapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2].
2-((4R)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,2-dimethylpentanamido)ethane-1-sulfonic acid
C28H49NO6S (527.3280414000001)
His Ile Lys Met
C23H41N7O5S (527.2889736000001)
His Ile Met Lys
C23H41N7O5S (527.2889736000001)
His Lys Ile Met
C23H41N7O5S (527.2889736000001)
His Lys Leu Met
C23H41N7O5S (527.2889736000001)
His Lys Met Ile
C23H41N7O5S (527.2889736000001)
His Lys Met Leu
C23H41N7O5S (527.2889736000001)
His Leu Lys Met
C23H41N7O5S (527.2889736000001)
His Leu Met Lys
C23H41N7O5S (527.2889736000001)
His Met Ile Lys
C23H41N7O5S (527.2889736000001)
His Met Lys Ile
C23H41N7O5S (527.2889736000001)
His Met Lys Leu
C23H41N7O5S (527.2889736000001)
His Met Leu Lys
C23H41N7O5S (527.2889736000001)
Ile His Lys Met
C23H41N7O5S (527.2889736000001)
Ile His Met Lys
C23H41N7O5S (527.2889736000001)
Ile Ile Pro Trp
Ile Ile Trp Pro
Ile Lys His Met
C23H41N7O5S (527.2889736000001)
Ile Lys Met His
C23H41N7O5S (527.2889736000001)
Ile Leu Pro Trp
Ile Leu Trp Pro
Ile Met His Lys
C23H41N7O5S (527.2889736000001)
Ile Met Lys His
C23H41N7O5S (527.2889736000001)
Ile Pro Ile Trp
Ile Pro Leu Trp
Ile Pro Trp Ile
Ile Pro Trp Leu
Ile Trp Ile Pro
Ile Trp Leu Pro
Ile Trp Pro Ile
Ile Trp Pro Leu
Lys His Ile Met
C23H41N7O5S (527.2889736000001)
Lys His Leu Met
C23H41N7O5S (527.2889736000001)
Lys His Met Ile
C23H41N7O5S (527.2889736000001)
Lys His Met Leu
C23H41N7O5S (527.2889736000001)
Lys Ile His Met
C23H41N7O5S (527.2889736000001)
Lys Ile Met His
C23H41N7O5S (527.2889736000001)
Lys Lys Pro Arg
Lys Lys Arg Pro
Lys Leu His Met
C23H41N7O5S (527.2889736000001)
Lys Leu Met His
C23H41N7O5S (527.2889736000001)
Lys Met His Ile
C23H41N7O5S (527.2889736000001)
Lys Met His Leu
C23H41N7O5S (527.2889736000001)
Lys Met Ile His
C23H41N7O5S (527.2889736000001)
Lys Met Leu His
C23H41N7O5S (527.2889736000001)
Lys Pro Lys Arg
Lys Pro Gln Arg
C22H41N9O6 (527.3179646000001)
Lys Pro Arg Lys
Lys Pro Arg Gln
C22H41N9O6 (527.3179646000001)
Lys Gln Pro Arg
C22H41N9O6 (527.3179646000001)
Lys Gln Arg Pro
C22H41N9O6 (527.3179646000001)
Lys Arg Lys Pro
Lys Arg Pro Lys
Lys Arg Pro Gln
C22H41N9O6 (527.3179646000001)
Lys Arg Gln Pro
C22H41N9O6 (527.3179646000001)
Leu His Lys Met
C23H41N7O5S (527.2889736000001)
Leu His Met Lys
C23H41N7O5S (527.2889736000001)
Leu Ile Pro Trp
Leu Ile Trp Pro
Leu Lys His Met
C23H41N7O5S (527.2889736000001)
Leu Lys Met His
C23H41N7O5S (527.2889736000001)
Leu Leu Pro Trp
Leu Leu Trp Pro
Leu Met His Lys
C23H41N7O5S (527.2889736000001)
Leu Met Lys His
C23H41N7O5S (527.2889736000001)
Leu Pro Ile Trp
Leu Pro Leu Trp
Leu Pro Trp Ile
Leu Pro Trp Leu
Leu Trp Ile Pro
Leu Trp Leu Pro
Leu Trp Pro Ile
Leu Trp Pro Leu
Met His Ile Lys
C23H41N7O5S (527.2889736000001)
Met His Lys Ile
C23H41N7O5S (527.2889736000001)
Met His Lys Leu
C23H41N7O5S (527.2889736000001)
Met His Leu Lys
C23H41N7O5S (527.2889736000001)
Met Ile His Lys
C23H41N7O5S (527.2889736000001)
Met Ile Lys His
C23H41N7O5S (527.2889736000001)
Met Lys His Ile
C23H41N7O5S (527.2889736000001)
Met Lys His Leu
C23H41N7O5S (527.2889736000001)
Met Lys Ile His
C23H41N7O5S (527.2889736000001)
Met Lys Leu His
C23H41N7O5S (527.2889736000001)
Met Leu His Lys
C23H41N7O5S (527.2889736000001)
Met Leu Lys His
C23H41N7O5S (527.2889736000001)
Pro Ile Ile Trp
Pro Ile Leu Trp
Pro Ile Trp Ile
Pro Ile Trp Leu
Pro Lys Lys Arg
Pro Lys Gln Arg
C22H41N9O6 (527.3179646000001)
Pro Lys Arg Lys
Pro Lys Arg Gln
C22H41N9O6 (527.3179646000001)
Pro Leu Ile Trp
Pro Leu Leu Trp
Pro Leu Trp Ile
Pro Leu Trp Leu
Pro Gln Lys Arg
C22H41N9O6 (527.3179646000001)
Pro Gln Arg Lys
C22H41N9O6 (527.3179646000001)
Pro Arg Lys Lys
Pro Arg Lys Gln
C22H41N9O6 (527.3179646000001)
Pro Arg Gln Lys
C22H41N9O6 (527.3179646000001)
Pro Trp Ile Ile
Pro Trp Ile Leu
Pro Trp Leu Ile
Pro Trp Leu Leu
Gln Lys Pro Arg
C22H41N9O6 (527.3179646000001)
Gln Lys Arg Pro
C22H41N9O6 (527.3179646000001)
Gln Pro Lys Arg
C22H41N9O6 (527.3179646000001)
Gln Pro Arg Lys
C22H41N9O6 (527.3179646000001)
Gln Arg Lys Pro
C22H41N9O6 (527.3179646000001)
Gln Arg Pro Lys
C22H41N9O6 (527.3179646000001)
Arg Lys Lys Pro
Arg Lys Pro Lys
Arg Lys Pro Gln
C22H41N9O6 (527.3179646000001)
Arg Lys Gln Pro
C22H41N9O6 (527.3179646000001)
Arg Pro Lys Lys
Arg Pro Lys Gln
C22H41N9O6 (527.3179646000001)
Arg Pro Gln Lys
C22H41N9O6 (527.3179646000001)
Arg Gln Lys Pro
C22H41N9O6 (527.3179646000001)
Arg Gln Pro Lys
C22H41N9O6 (527.3179646000001)
Trp Ile Ile Pro
Trp Ile Leu Pro
Trp Ile Pro Ile
Trp Ile Pro Leu
Trp Leu Ile Pro
Trp Leu Leu Pro
Trp Leu Pro Ile
Trp Leu Pro Leu
Trp Pro Ile Ile
Trp Pro Ile Leu
Trp Pro Leu Ile
Trp Pro Leu Leu
Daphniphylline
Fesoterodine Fumarate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Fesoterodine Fumarate is an orally active, nonsubtype selective, competitive muscarinic receptor (mAChR) antagonist with pKi values of 8.0, 7.7, 7.4, 7.3, 7.5 for M1, M2, M3, M4, M5 receptors, respectively. Fesoterodine Fumarate is used for the overactive bladder (OAB)[1][2].
Gemcitabine elaidate
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate maleate
N-[(2S,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2R,4aS,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2S,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(2R,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
2-((4R)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,2-dimethylpentanamido)ethane-1-sulfonic acid
C28H49NO6S (527.3280414000001)
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclohexanecarboxamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(2R,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C28H50NO6P (527.3375570000001)
(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]hexadeca-4,8,12-triene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
(4E,8E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]dodeca-4,8-diene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
(4E,8E,12E)-2-(decanoylamino)-3-hydroxynonadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tetradeca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)hexadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]pentadeca-4,8-diene-1-sulfonic acid
2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytridecane-1-sulfonic acid
(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytridec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]dec-4-ene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)octadeca-4,8,12-triene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)pentadeca-4,8,12-triene-1-sulfonic acid
(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]undec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]undecane-1-sulfonic acid
(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydodec-4-ene-1-sulfonic acid
(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytrideca-4,8-diene-1-sulfonic acid
(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)tetradeca-4,8,12-triene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]hexadeca-4,8-diene-1-sulfonic acid
(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid
4-[3-acetyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(Z)-hexadec-9-enoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-pentanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-hexanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-butanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] acetate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] butanoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate
PE(22:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(19:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LdMePE(20:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(18:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved